Loading…
Gerresheimer is acquiring Swiss technology company Sensile Medical AG for a maximum purchase price of EUR 350 million, with an initial payment of EUR 175 million. The acquisition extends Gerresheimer's business model toward OEM drug delivery platforms with digital and electronic capabilities.
Sensile Medical announced a partnership with Verily and Sanofi to develop and commercialize a connected insulin patch pump for people with Type II diabetes.